Google Ventures
VC Fund
Mountain View, United States
Google Ventures is a VC fund in Mountain View focused on Software and Health Care. Google Ventures invests in sectors including life sciences, consumer, enterprise, crypto, climate, and frontier technology. With Alphabet as its sole limited partner, Google Ventures focuses on long-term investments. Its operating partners assist startups in design, equity, diversity & inclusion, talent, and engineering and help them connectwith Google for technology and expertise. Founded in 2009 as Google Ventures, Google Ventures manages over $8 billion in assets with 400 active portfolio companies in North America and Europe. Some notable investments include Uber, Nest, Slack, GitLab, and One Medical. Google Ventures is based in the San Francisco Bay Area with offices in Cambridge, New York, and London.
- Total investments:
- 1459
- Last investment:
- Lead investor:
- 31%
- Fund size:
- $100M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Google Ventures invests in
Stages Google Ventures invests in
Countries Google Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 24 contacts → | |||
Round size
- Seed
- $1.2M–$16M
- Series A
- $6M–$100M
- Series B
- $16M–$121M
Investment Focus
Industry
- Software 171 (12%)
- Health Care 111 (8%)
- Biotechnology 102 (7%)
- SaaS 65 (4%)
- Artificial Intelligence 65 (4%)
Stage
- Series A 219 (15%)
- Series B 206 (14%)
- Seed 153 (10%)
- Series C 128 (9%)
- Series D 76 (5%)
Country
- United States 525 (36%)
- United Kingdom 35 (2%)
- Israel 4 (0%)
- Switzerland 4 (0%)
- Canada 2 (0%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Andy Wheeler
Partner
|
Partner | Total investments: 38 | Find email | |
Anika Gupta
Principal
|
Principal | Total investments: 4 | Find email | |
Anthony Philippakis
Venture Partner
|
Venture Partner | Total investments: 25 | Find email | |
Ben Robbins
General Partner
|
General Partner | Total investments: 25 | Find email | |
Bethany Tsui
Principal and Investor
|
Principal and Investor | Total investments: 0 | Find email | |
| See all 24 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Encoded Therapeutics
|
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad range of severe genetic disorders. The company's therapy pipeline addresses devastating genetic and acquired disorders spanning multiple disease pathways including neurocircuitry, metabolic disorders, neurodegeneration and cardiovasculardisease, enabling medical practitioners to treat patients and improve their lives. | $275M / Series F / Sep 09, 2026 | |
|
Encoded Therapeutics
|
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad range of severe genetic disorders. The company's therapy pipeline addresses devastating genetic and acquired disorders spanning multiple disease pathways including neurocircuitry, metabolic disorders, neurodegeneration and cardiovasculardisease, enabling medical practitioners to treat patients and improve their lives. | $275M / Series F / Sep 09, 2026 | |
Blacksmith
|
Blacksmith provides cloud infrastructure for continuous integration, enabling developers to build, test, and deploy software. | $45M / Series B / Aug 12, 2026 | |
Engine Biosciences
|
Engine Biosciences is a biotech company that applies machine learning to genomics for drug discovery.Engine Biosciences is a venture-backed San Francisco- and Asia-based technology company pioneering network biomedicine. The company's proprietary and patented technologies oriented around deciphering the complexity of biology networks includeboth high-throughput wet lab experimentation and artificial intelligence algorithms for drug discovery and cellular reprogramming. This platform, developed through several years of research by our scientific founding and leadership team who include faculty members at MIT, Harvard, Mayo Clinic, and UCSD, dramatically accelerates and reduces costs of the R&D process for new medical therapies. We are actively applying the platform internally and with partners across a range of disease indications. | $5M / Venture - Series Unknown / Aug 10, 2026 | |
LifeMine Therapeutics
|
Discovering powerful new drugs from eukaryotic microbes by combining Genomics with AI and Synthetic Biology. Founded by Gregory Verdine, PhD, Rick Klausner, MD and WeiQing Zhou, MBA, LifeMine Therapeutics is headquartered in Cambridge, Massachusetts. | $188M / Series E / Aug 06, 2026 | |
|
LifeMine Therapeutics
|
Discovering powerful new drugs from eukaryotic microbes by combining Genomics with AI and Synthetic Biology. Founded by Gregory Verdine, PhD, Rick Klausner, MD and WeiQing Zhou, MBA, LifeMine Therapeutics is headquartered in Cambridge, Massachusetts. | $188M / Series E / Aug 06, 2026 | |
Obsidian Security
|
Obsidian Security provides SaaS and AI security software that detects threats, manages risks, and secures enterprise applications. | $85M / Series D / Aug 04, 2026 | |
Wonder
|
Wonder is a food technology company that operates a mealtime platform offering restaurant meals, prepared foods, meal kits, and food delivery through a unified ordering experience. It develops and manages food preparation, ordering, and delivery using proprietary technology, including its Infinite Kitchen food robotics platform. The companypartners with chefs and restaurant brands to provide a variety of meal options that customers can order through its platform. It also manages the preparation and fulfillment process to support delivery and pickup services across its locations. Additionally, Wonder expands its food ecosystem through the operation and integration of restaurant concepts, meal kit services, and delivery capabilities. | $650M / Series D / Jul 16, 2026 | |
Nebex
|
NEBEX is a successful middle market investment intermediary. NEBEX, has completed over 100 transactions throughout the United States. New England Business Exchange concentrates on representing sellers whose business appeals to large corporate buyers or private equity groups. | $30M / Seed / Jun 29, 2026 | |
Verse
|
Verse helps large energy buyers Connect, Contain, and Control their global power portfolios: connect to the grid faster leveraging flexibility; contain energy cost and risk with real-time analytics and strategic procurement; and control assets to maximize portfolio value through real-time optimization. Verse team blends deep energy-market expertisewith modern software engineering and product design to deliver usable, scalable tools to manage power costs and risks. | $54M / Series B / Jun 18, 2026 | |
| See all 1459 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Google Ventures invest in?
Google Ventures invests primarily in Software, Health Care and Biotechnology startups, most often at Series A and Series B stage. Most of the 1,459 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Google Ventures's check size?
Google Ventures typically joins rounds of $1.2M–$16M at Seed, $6M–$100M at Series A and $16M–$121M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Google Ventures participates in.
How do I contact Google Ventures?
Public channels for Google Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Google Ventures?
The team at Google Ventures includes Andy Wheeler (Partner), Anika Gupta (Principal) and Anthony Philippakis (Venture Partner), among 24 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
